Sphera Funds Management Ltd. Immatics N.V. Transaction History
Sphera Funds Management Ltd.
- $380 Million
- Q1 2025
A detailed history of Sphera Funds Management Ltd. transactions in Immatics N.V. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 921,111 shares of IMTX stock, worth $4.71 Million. This represents 1.09% of its overall portfolio holdings.
Number of Shares
921,111
Previous 921,111
-0.0%
Holding current value
$4.71 Million
Previous $6.55 Million
36.57%
% of portfolio
1.09%
Previous 1.35%
Shares
14 transactions
Others Institutions Holding IMTX
# of Institutions
82Shares Held
91.5MCall Options Held
201KPut Options Held
109K-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.7MShares$75 Million0.04% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$47.9 Million1.77% of portfolio
-
Suvretta Capital Management, LLC New York, NY9.14MShares$46.7 Million1.8% of portfolio
-
Wellington Management Group LLP Boston, MA8.58MShares$43.9 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$37.2 Million0.39% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $390M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...